Diagnostic company Dr Lal PathLabs is undertaking a major expansion plan including diversifying into new segments such as clinical trials, and offering managed services to hospitals to run in-house laboratories on a revenue-sharing model. The company is doubling the number of laboratories from 50 to 100 and collection centres from 700 to 1,000 over the next one year.
The company is targeting a turnover of Rs 240 crore next year compared to Rs 172 crore at the end of this fiscal. The company will now move into Tier-II and Tier-III cities in the North and East regions by setting up new labs and collection centres.
In the West and South regions, where the company so far has not had much presence, the diagnostics firm is looking to acquire local labs